Every time our body encounters a new disease-causing agent, a crucial defence system called adaptive immunity comes into play. T cells, the top agents ...

Seismic Therapeutic Inc. has provided preclinical data for S-4321, a novel dual-cell bidirectional (DcB) PD-1:FcγRIIb antibody being developed for the treatment of autoimmune disease.